<DOC>
	<DOC>NCT00911235</DOC>
	<brief_summary>This study is designed to estimate the effect of fluconazole (200 mg BID for 2 days), a moderate CYP3A4 inhibitor on the pharmacokinetics of a single 8 mg oral dose of fesoterodine in healthy adult subjects.</brief_summary>
	<brief_title>The Effect Of Fluconazole On Pharmacokinetics Of Fesoterodine In Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Urinary Incontinence</mesh_term>
	<mesh_term>Enuresis</mesh_term>
	<mesh_term>Urinary Bladder, Overactive</mesh_term>
	<mesh_term>Urinary Incontinence, Urge</mesh_term>
	<mesh_term>Fluconazole</mesh_term>
	<mesh_term>Fesoterodine</mesh_term>
	<criteria>Healthy subjects between the ages of 18 and 55 years Not healthy subjects. subjects with acute or chronic medical or psychiatric condition or laboratory abnormality</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>The Effect Of Fluconazole On Pharmacokinetics Of Fesoterodine In Healthy Subjects</keyword>
</DOC>